Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Heritage Cannabis Holdings Corp TRJTF


Primary Symbol: HERTF

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.


PINL:HERTF - Post by User

Comment by Budamanon Feb 09, 2019 1:34pm
127 Views
Post# 29342241

RE:Sharples on EBITDA.

RE:Sharples on EBITDA.Really, Bobby? Did you think I would ignore such rubbish. You know as well as I do that what you are hinting at is false and misleading, and a lame attempt to try and short this stock. If you believe in your statement, stop hiding behind questions and say what you mean - or are you worried about being sued? Keep in mind that you do not use a rotating IP address. It is quite static. If you want to know how Sharples arrived at those numbers, ask him. Ask his accountant, instead of skulking in the shadows like the Troll you are. In my opinion only - Buda
BobGreenfield wrote: Purefarma is said to have had revenues of $2,000,000 with EBITDA of $500,000 or EBITDA of $0.015/share based on Purefarma's 33,000,000 shares.

Sharples has been promoting revenue projections of $40,000,000 with an EBITDA of $0.04/share based on 400,000,000 shares.

All things being equal .......... the EBITDA on the $40,000,000 projection should reflect as EBITDA of $0.025/share.

I wonder how Sharples came up with the EBITDA  of $0.04/share.




Bullboard Posts